EGFR activation elicited adaptive resistance to lorlatinib in ALK-rearranged non-small cell lung cancer cells

被引：0
|
作者：
Katayama, Yuki [1 ]
Yamada, Tadaaki [1 ]
Tanimura, Keiko [1 ]
Morimoto, Kenji [1 ]
Yoneda, Kazue [2 ]
Horinaka, Mano [3 ]
Sakai, Toshiyuki [3 ]
Ozasa, Hiroaki [4 ]
Takayama, Koichi [1 ]
机构：
[1] Kyoto Prefectural Univ Med, Dept Pulm Med, Grad Sch Med Sci, Kyoto, Japan
[2] Hyogo Coll Med, Dept Omics Med, Nishinomiya, Hyogo, Japan
[3] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Drug Discovery Med, Kyoto, Japan
[4] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MO38-3
引用
收藏
页码：S1421 / S1421
页数：1
相关论文
共 50 条
  • [31] Response to lorlatinib on a patient with ALK-rearranged non-small cell lung cancer harboring 1151Tins mutation with uterine metastasis
    Kobayashi, Takashi
    Kanda, Shintaro
    Fukushima, Toshirou
    Noguchi, Takuro
    Sekiguchi, Nodoka
    Koizumi, Tomonobu
    THORACIC CANCER, 2021, 12 (16) : 2275 - 2278
  • [32] Ceritinib-a second-generation ALK inhibitor overcoming resistance in ALK-rearranged non-small cell lung cancer
    Rothschild, Sacha I.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2014, 3 (06) : 379 - 381
  • [33] A systemic review of resistance mechanisms and ongoing clinical trials in ALK-rearranged non-small cell lung cancer
    Esfahani, Khashayar
    Agulnik, Jason Scott
    Cohen, Victor
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [34] Ceritinib in ALK-Rearranged Non-Small-Cell Lung Cancer
    Shaw, Alice T.
    Kim, Dong-Wan
    Mehra, Ranee
    Tan, Daniel S. W.
    Felip, Enriqueta
    Chow, Laura Q. M.
    Camidge, D. Ross
    Vansteenkiste, Johan
    Sharma, Sunil
    De Pas, Tommaso
    Riely, Gregory J.
    Solomon, Benjamin J.
    Wolf, Juergen
    Thomas, Michael
    Schuler, Martin
    Liu, Geoffrey
    Santoro, Armando
    Lau, Yvonne Y.
    Goldwasser, Meredith
    Boral, Anthony L.
    Engelman, Jeffrey A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (13): : 1189 - 1197
  • [35] Ceritinib in ALK-Rearranged Non-Small-Cell Lung Cancer
    Shen, Liang
    Ji, Hong-Fang
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (26): : 2537 - 2537
  • [36] Efficacy of gilteritinib in comparison with alectinib for the treatment of ALK-rearranged non-small cell lung cancer
    Ando, Chihiro
    Ichihara, Eiki
    Nishi, Tatsuya
    Morita, Ayako
    Hara, Naofumi
    Takada, Kenji
    Nakasuka, Takamasa
    Watanabe, Hiromi
    Kano, Hirohisa
    Nishii, Kazuya
    Makimoto, Go
    Kondo, Takumi
    Ninomiya, Kiichiro
    Fujii, Masanori
    Kubo, Toshio
    Ohashi, Kadoaki
    Matsuoka, Ken-ichi
    Hotta, Katsuyuki
    Tabata, Masahiro
    Maeda, Yoshinobu
    Kiura, Katsuyuki
    CANCER SCIENCE, 2023, 114 (11) : 4343 - 4354
  • [37] Treatment of ALK-Rearranged Non-Small Cell Lung Cancer: Recent Progress and Future Directions
    Laird Cameron
    Benjamin Solomon
    Drugs, 2015, 75 : 1059 - 1070
  • [38] Imaging Features and Metastatic Patterns of Advanced ALK-Rearranged Non-Small Cell Lung Cancer
    Mendoza, Dexter P.
    Lin, Jessica J.
    Rooney, Marguerite M.
    Chen, Tianqi
    Sequist, Lecia V.
    Shaw, Alice T.
    Digumarthy, Subba R.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2020, 214 (04) : 766 - 774
  • [39] New Strategies for Treatment of ALK-Rearranged Non-Small Cell Lung Cancers
    Sasaki, Takaaki
    Jaenne, Pasi A.
    CLINICAL CANCER RESEARCH, 2011, 17 (23) : 7213 - 7218
  • [40] ALK-Rearranged Non-Small Cell Lung Cancer is Associated with a High Rate of Venous Thromboembolism
    Zer, Alona
    Moskovitz, Mor
    Hwang, David
    Hershko-Klement, Anat
    Fridel, Ludmila
    Korpanty, Grzegorz
    Dudnik, Elizabeth
    Peled, Nir
    Shochat, Tzippy
    Leighl, Natasha
    Liu, Geoffrey
    Feld, Ronald
    Burkes, Ronald
    Wollner, Mira
    Tsao, Ming
    Shepherd, Frances
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S326 - S327
12345